CARE Ratings Ltd.

NSE: CARERATING | BSE: 534804 | ISIN: INE752H01013 | Industry: Other Financial Services
| Mid-range Performer
1650.8000 -16.20 (-0.97%)
NSE May 07, 2026 15:31 PM
Volume: 20,832
 

logo
CARE Ratings Ltd.
03 Feb 2017
1650.80
-0.97%
Rudra Shares and Stock Brokers Ltd
With this acquisition, Excel crop would benefit in near term as global players are looking at India to increase their market share, add to their product portfolio, and strengthen their supply base in specialty and agrochemicals. Additionally, as a part of the strategic direction, it has decided to focus on speciality chemicals, pharma intermediates, pharma actives, performance chemicals and environment and biotech products as a primary focus for its future activities. Combining of ECCL's strong manufacturing capabilities along with SCC's world class research capabilities will take the company to greater heights. In addition to the company, Indian farmers will also stand benefited due to access to world renowned technologies and products and would lead...
CARE Ratings has gained 32.13% in the last 1 Year
More from CARE Ratings Ltd.
Recommended